Endurance RP Aktie

View in Terminal

Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2013, Endurance RP Aktie has already paid €2.57 in dividends. The last payout was in March 2013.

Financials

In the last quarter, Endurance RP Aktie had revenue of €4.64M and net profit of €475.51K

(EUR)	June 2026	YoY
Revenue	4.64M	-
Gross profit	4.64M	-
Net profit	475.51K	-
EBITDA	1.21M	-

Fundamentals

Metric	Value
Market capitalization	€26.71M
Number of shares	291.82M
52-week high/low	€0.14 - €0.0652
Dividends	No
Beta	1.12
P/E ratio	-15.23
PEG ratio	-0.26
P/B ratio	-4.92
P/S ratio	5.49

Company profile

Endurance RP Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in the People's Republic of China, Europe, Hong Kong, and Taiwan. The company operates in two segments, Biopharma and Corporate Investment. It engages in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management and corporate finance services. The company was formerly known as Regent Pacific Group Limited and changed its name to Endurance RP Limited in June 2021. Endurance RP Limited was incorporated in 1991 and is headquartered in Central, Hong Kong.